Knowledge, Attitudes, Willingness to Pay, and Patient Preferences About Genetic Testing and Subsequent Risk Management for Cancer Prevention

[1]  Anne Lanceley,et al.  Awareness, knowledge, perceptions, and attitudes towards genetic testing for cancer risk among ethnic minority groups: a systematic review , 2017, BMC Public Health.

[2]  M. Palmer,et al.  Parental acceptance and uptake of the HPV vaccine among African-Americans and Latinos in the United States: A literature review. , 2016, Social science & medicine.

[3]  A. Eisen,et al.  Is it time to offer BRCA1 and BRCA2 testing to all Jewish women? , 2015, Current oncology.

[4]  M. King,et al.  Precision medicine meets public health: population screening for BRCA1 and BRCA2. , 2014, Journal of the National Cancer Institute.

[5]  R. Bennett,et al.  A practice guideline from the American College of Medical Genetics and Genomics and the National Society of Genetic Counselors: referral indications for cancer predisposition assessment , 2014, Genetics in Medicine.

[6]  M. King,et al.  Population-based screening for breast and ovarian cancer risk due to BRCA1 and BRCA2 , 2014, Proceedings of the National Academy of Sciences.

[7]  M. Hall,et al.  Cost Sharing and Hereditary Cancer Risk: Predictors of Willingness-to-Pay for Genetic Testing , 2014, Journal of Genetic Counseling.

[8]  Rongwei Fu,et al.  Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer in Women: A Systematic Review to Update the U.S. Preventive Services Task Force Recommendation , 2014, Annals of Internal Medicine.

[9]  J. George,et al.  BRCA mutation frequency and patterns of treatment response in BRCA mutation-positive women with ovarian cancer: a report from the Australian Ovarian Cancer Study Group. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  K. Hughes,et al.  Hereditary Breast and Ovarian Cancer and Other Hereditary Syndromes: Using Technology to Identify Carriers , 2012, Annals of Surgical Oncology.

[11]  C. Isaacs,et al.  Long‐term outcomes of BRCA1/BRCA2 testing: risk reduction and surveillance , 2012, Cancer.

[12]  M. Freedman,et al.  The genetics of cancer risk. , 2011, Cancer journal.

[13]  Julie O. Culver,et al.  Genetics, genomics, and cancer risk assessment , 2011, CA: a cancer journal for clinicians.

[14]  T. Tymstra,et al.  The attitude of women toward current and future possibilities of diagnostic testing in maternal blood using fetal DNA , 2009, Prenatal diagnosis.

[15]  Susan M. Domchek,et al.  Meta-analysis of Risk Reduction Estimates Associated With Risk-Reducing Salpingo-oophorectomy in BRCA1 or BRCA2 Mutation Carriers , 2009, Journal of the National Cancer Institute.

[16]  L. Hartmann,et al.  Proceedings of the International Consensus Conference on Breast Cancer Risk, Genetics, & Risk Management, April, 2007 , 2008, Cancer.

[17]  R. Eeles,et al.  Predicting the likelihood of carrying a BRCA1 or BRCA2 mutation: validation of BOADICEA, BRCAPRO, IBIS, Myriad and the Manchester scoring system using data from UK genetics clinics , 2008, Journal of Medical Genetics.

[18]  T. Rebbeck,et al.  Factors determining dissemination of results and uptake of genetic testing in families with known BRCA1/2 mutations. , 2008, Genetic testing.

[19]  J. Haddow,et al.  Screen positive rates among six family history screening protocols for breast/ovarian cancer in four cohorts of women , 2008, Familial Cancer.

[20]  K. Offit,et al.  Clinical practice. Management of an inherited predisposition to breast cancer. , 2007, The New England journal of medicine.

[21]  K. Hudson.  Prohibiting genetic discrimination. , 2007, The New England journal of medicine.

[22]  Barry Rosen,et al.  Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kin-cohort study in Ontario, Canada. , 2006, Journal of the National Cancer Institute.

[23]  M. Cho,et al.  How Do Women Decide? Accepting or Declining BRCA1/2 Testing in a Nationwide Clinical Sample in the United States , 2006, Public Health Genomics.

[24]  J. Haddow,et al.  Screen-positive rates and agreement among six family history screening protocols for breast/ovarian cancer in a population-based cohort of 21- to 55-year-old women , 2006, Genetics in Medicine.

[25]  D. Timmermans,et al.  Are pregnant women making informed choices about prenatal screening? , 2005, Genetics in Medicine.

[26]  K. Armstrong,et al.  The association between race and attitudes about predictive genetic testing. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[27]  R. Ellis.  International Consensus Conference on Breast Cancer. , 2002, Journal of the American College of Surgeons.

[28]  A Y Kinney,et al.  Knowledge, attitudes, and interest in breast-ovarian cancer gene testing: a survey of a large African-American kindred with a BRCA1 mutation. , 2001, Preventive medicine.

[29]  T. Sellers,et al.  Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers. , 2001, Journal of the National Cancer Institute.

[30]  J. Kaprio,et al.  Environmental and heritable factors in the causation of cancer--analyses of cohorts of twins from Sweden, Denmark, and Finland. , 2000, The New England journal of medicine.

[31]  Barbara L. Smith,et al.  Germ-line BRCA1 mutations in Jewish and non-Jewish women with early-onset breast cancer. , 1996, The New England journal of medicine.

[32]  A. Jemal,et al.  Cancer statistics, 2018 , 2018, CA: a cancer journal for clinicians.

[33]  D. Brizel,et al.  National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology , 2012 .

[34]  A. Surbone.  Social and ethical implications of BRCA testing. , 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

[35]  K. Offit,et al.  American Society of Clinical Oncology policy statement update: genetic and genomic testing for cancer susceptibility. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[36]  C. Verhaak,et al.  Genetic uptake in BRCA-mutation families is related to emotional and behavioral communication characteristics of index patients , 2004, Familial Cancer.